Patents by Inventor Marja T. Nevalainen

Marja T. Nevalainen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the inhibition of Stat5 in prostate cancer cells
    Patent number: 8609624
    Abstract: The present invention relates to compositions and methods for the treatment of prostate cancer. In certain embodiments, the invention relates to compositions and methods for the inhibition of prostate cancer cell growth, comprising inhibiting the activity of Stat5 in prostate cancer cells.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: December 17, 2013
    Assignee: Georgetown University
    Inventor: Marja T. Nevalainen
  • METHODS AND COMPOSITIONS FOR THE INHIBITION OF STAT5 IN PROSTATE CANCER CELLS
    Publication number: 20130183318
    Abstract: The present invention relates to compositions and methods for the treatment of prostate cancer. In certain embodiments, the invention relates to compositions and methods for the inhibition of prostate cancer cell growth, comprising inhibiting the activity of Stat5 in prostate cancer cells.
    Type: Application
    Filed: May 22, 2012
    Publication date: July 18, 2013
    Applicant: GEORGETOWN UNIVERSITY
    Inventor: MARJA T. NEVALAINEN
  • METHODS AND COMPOSITIONS FOR THE INHIBITION OF STAT5 IN PROSTATE CANCER CELLS
    Publication number: 20120321639
    Abstract: The present invention relates to compositions and methods for the treatment of prostate cancer. In certain embodiments, the invention relates to compositions and methods for the inhibition of prostate cancer cell growth, comprising inhibiting the activity of Stat5 in prostate cancer cells.
    Type: Application
    Filed: May 22, 2012
    Publication date: December 20, 2012
    Applicant: GEORGETOWN UNIVERSITY
    Inventor: MARJA T. NEVALAINEN
  • Methods and compositions for the inhibition of Stat5 in prostate cancer cells
    Patent number: 8202849
    Abstract: The present invention relates to compositions and methods for the treatment of prostate cancer. In certain embodiments, the invention relates to compositions and methods for the inhibition of prostate cancer cell growth, comprising inhibiting the activity of Stat5 in prostate cancer cells.
    Type: Grant
    Filed: August 26, 2009
    Date of Patent: June 19, 2012
    Assignee: Georgetown University
    Inventor: Marja T. Nevalainen
  • METHODS AND COMPOSITIONS FOR THE INHIBITION OF STAT5 IN PROSTATE CANCER CELLS
    Publication number: 20100120892
    Abstract: The present invention relates to compositions and methods for the treatment of prostate cancer. In certain embodiments, the invention relates to compositions and methods for the inhibition of prostate cancer cell growth, comprising inhibiting the activity of Stat5 in prostate cancer cells.
    Type: Application
    Filed: August 26, 2009
    Publication date: May 13, 2010
    Applicant: Georgetown University
    Inventor: Marja T. Nevalainen
  • Method for predicting responsiveness of breast cancer to antiestrogen therapy
    Patent number: 7642050
    Abstract: The invention is directed to diagnostic and monitoring methods (assays) for cancer and kits that may be used in such methods. More particularly, an aspect of the invention relates to the use of activated Stat5 for diagnosing and monitoring breast cancer and predicting the effectiveness of cancer treatment. The invention also relates to the use of screening assays for discovering compounds that effect levels of activated Stat5.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: January 5, 2010
    Inventors: Marja T. Nevalainen, Hallgeir Rui
  • Diagnostic and monitoring methods for cancer
    Patent number: 7306921
    Abstract: The invention is directed to diagnostic and monitoring methods (assays) for cancer and kits that may be used in such methods. More particularly, an aspect of the invention relates to the use of activated Stat5 for diagnosing and monitoring breast cancer and predicting the effectiveness of cancer treatment. The invention also relates to the use of screening assays for discovering compounds that effect levels of activated Stat5.
    Type: Grant
    Filed: March 3, 2003
    Date of Patent: December 11, 2007
    Inventors: Marja T. Nevalainen, Hallgeir Rui
  • Diagnostic and monitoring methods for cancer
    Publication number: 20030224465
    Abstract: The invention is directed to diagnostic and monitoring methods (assays) for cancer and kits that may be used in such methods. More particularly, an aspect of the invention relates to the use of activated Stat5 for diagnosing and monitoring breast cancer and predicting the effectiveness of cancer treatment. The invention also relates to the use of screening assays for discovering compounds that effect levels of activated Stat5.
    Type: Application
    Filed: March 3, 2003
    Publication date: December 4, 2003
    Applicant: Advantex Bioreagents Llp
    Inventors: Marja T. Nevalainen, Hallgeir Rui
  • Diagnostic and monitorings methods for cancer
    Publication number: 20020132274
    Abstract: The invention is directed to diagnostic and monitoring methods (assays) for cancer and kits that may be used in such methods. More particularly, an aspect of the invention relates to the use of activated Stat5 for diagnosing and monitoring breast cancer and predicting the effectiveness of cancer treatment. The invention also relates to the use of screening assays for discovering compounds that effect levels of activated Stat5.
    Type: Application
    Filed: January 17, 2001
    Publication date: September 19, 2002
    Inventors: Marja T. Nevalainen, Hallgeir Rui